《外圍股市》歐洲主要股市早段續升0.4%-0.8%
英偉達(NVDA.US)上季收入及本季展望收入遠勝預期,股價盤後續漲6.6%再破頂,帶動已三連漲的納指一百期貨持續跑贏,最報15,392,續升1.3%;標普五百期貨續彈0.6%;道指期貨僅窄幅偏穩。
昨晚跑輸的歐元區主要股市早段追升,德國DAX及法國CAC高見15,896及7,343,現報15,839及7,307,續升0.7%及0.8%;意大利FTSE MIB高見28,544,現報28,419,續升近0.7%;西班牙IBEX 35高見9,415,現報9,373,續升0.6%。泛歐600高見458.02,現報456.33,續升0.6%。英國富時100三連彈,最高見7,386,現報7,350,續升0.4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.